thanks , I read thru it.
This new drug seems to be promising yet in a trial setting I might get placebo
and end up straight SOC which for geno 4 means about 50-60% SVR and 48wks
pretty much for sure.They have 5 arms one being placebo. So that is a 20% chance
of getting placebo. According to Egypt trials from Romark I have a 21% chance
of not getting my SVR with Alinia+SOC.
With Alina it is a possible 79% @48wks and 36wks with early response.
Than there is the 17% chance of clearing Alinia mono. Small but true.
Also if I turn out to be a non responder or relapser on Alinia+SOC I will
have the PIs to retreat with in the future.
A Chief hepatologist told me this as for retreating with Telepravir after Alinia +SOC :
sustained virologic response rate is in the 40% range for nonresponders and 60-70% range for relapsers
Of course that is when Telepravir becomes available they will let me retreat with it
being geno 4.
If I were to do this trial and somehow fail there are no good fall back scenarios
right now.
The whole thing is like a big chess game only that it is not a game!
Anybody with Tx experience is welcome to weigh in please!
Scroll down to post :"Back From The Doctor",a a member Tom is investigating the same trial,you may wanna check it out.I dont know whole lot but good luck.
Thanks Rocker for pointing out this trial.Was not aware of it.
Looks like my study location (NYC) is not recruiting yet.
What do you know about RO5024048 (R7128) ?
I have no clue as to what to expect from this. I only know that I am currently naive
and I am looking for the best possible shot which excludes placebo
and SOC by itself.
As a geno 4 should I do Alinia plus SOC or the trial you mentioned above?
What would you do ?
Isnt this trial taking geno 4`s
http://www.clinicaltrials.gov/ct2/show/NCT00869661?term=RO5024048&rank=2